Motion Lab - Free
$0 for learning and evaluation, including frame review, calibration, core measurements, tracking, and local project saving.
Start freeClear current availability
Product access reflects maturity: open beta, qualified evaluation, invite-only beta, public foundation, or validation-stage review.
Biosystems One does not present placeholder enterprise prices or artificial discounts. When a commercial price is not established, the site says so directly.
$0 for learning and evaluation, including frame review, calibration, core measurements, tracking, and local project saving.
Start freeCurrently included without a card or trial clock. Beta access includes the present export, reporting, comparison, and estimation features.
Join the betaRequest-based guided evaluation for qualified users reviewing workflow, evidence, and current launch limitations.
Request evaluationDefined pilot discussions for organizations able to contribute structured domain and workflow feedback. Pricing is scoped with the pilot.
Discuss a pilotEDU and Professional editions are in invite-only closed beta. Participation does not authorize regulated or production reliance.
Review beta accessThe catalogue foundation is non-commercial. It does not offer checkout, inventory, supplier fulfilment, or paid recommendations.
Review catalogue scopeNo paid or App Store access is offered. Research and validation conversations may be considered for defined non-clinical protocols.
Review validation accessResearch, academic, and enterprise arrangements require a defined product, use case, user group, support scope, and data-handling review.
Review institutional optionsA written quote or agreement would identify the product, users, term, support scope, data boundaries, pilot or production status, payment terms, and any institution-specific requirements.
A contact request, beta registration, or discovery conversation does not create a license, service commitment, data-processing agreement, support SLA, or guarantee of acceptance.
Questions and answers
No permanent pricing promise is made. Current free and open-beta access is stated accurately, and material pricing changes will be communicated before they apply.
The product is in launch preparation. Evaluation is scoped so professional workflow, evidence, limitations, and data handling can be reviewed before broader access.
There is no published discount schedule. Institutional terms would depend on a defined product, scope, users, support needs, and release maturity.
Need institutional access?
We will respond with the appropriate current access path rather than a generic sales package.